Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125501782 | 12550178 | 2 | F | 201603 | 20160818 | 20160712 | 20160830 | EXP | GB-ELI_LILLY_AND_COMPANY-GB201607001265 | ELI LILLY AND CO | 62.00 | YR | M | Y | 0.00000 | 20160830 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125501782 | 12550178 | 1 | PS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | 2000 MG, CYCLICAL | U | U | 20509 | 2000 | MG | ||||||
125501782 | 12550178 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | 290 MG, CYCLICAL | U | U | 0 | 290 | MG | ||||||
125501782 | 12550178 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNKNOWN | U | U | 0 | 6 | MG | ||||||
125501782 | 12550178 | 4 | C | CEFALEXIN | CEPHALEXIN | 1 | UNK | 0 | |||||||||||
125501782 | 12550178 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
125501782 | 12550178 | 6 | C | DOMPERIDONE | DOMPERIDONE | 1 | UNK | 0 | |||||||||||
125501782 | 12550178 | 7 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125501782 | 12550178 | 1 | Product used for unknown indication |
125501782 | 12550178 | 2 | Product used for unknown indication |
125501782 | 12550178 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125501782 | 12550178 | OT |
125501782 | 12550178 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125501782 | 12550178 | Abdominal pain lower | |
125501782 | 12550178 | Back pain | |
125501782 | 12550178 | Body temperature increased | |
125501782 | 12550178 | Constipation | |
125501782 | 12550178 | Energy increased | |
125501782 | 12550178 | Erythema | |
125501782 | 12550178 | Eye disorder | |
125501782 | 12550178 | Fatigue | |
125501782 | 12550178 | Gout | |
125501782 | 12550178 | Haemoglobin decreased | |
125501782 | 12550178 | Infusion site haemorrhage | |
125501782 | 12550178 | Infusion site pain | |
125501782 | 12550178 | Mouth ulceration | |
125501782 | 12550178 | Myalgia | |
125501782 | 12550178 | Neutrophil count decreased | |
125501782 | 12550178 | Ocular hyperaemia | |
125501782 | 12550178 | Oral pain | |
125501782 | 12550178 | Underdose | |
125501782 | 12550178 | Urinary tract infection | |
125501782 | 12550178 | Vasospasm | |
125501782 | 12550178 | Visual impairment | |
125501782 | 12550178 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |